Completed PHASE1/PHASE2 INTERVENTIONAL NCT00067678

Soy Protein in Early Diabetic Nephropathy

Sponsor: National Center for Complementary and Integrative Health (NCCIH)

Conditions Diabetes Mellitus Diabetic Nephropathy

Interventions soy protein

Updated 6 times since 2017 Last updated: Aug 16, 2006 Started: Jul 31, 2001 Completion: Jun 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Diabetes Mellitus and Diabetic Nephropathy, this trial is completed. The trial is conducted by National Center for Complementary and Integrative Health (NCCIH) and has accumulated 6 data snapshots since 2001. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jul 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Complementary and Integrative Health (NCCIH)

Data source: National Center for Complementary and Integrative Health (NCCIH)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lexington, United States